Physiomics PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
179.20
132.40
266.70
138.90
209.80
571.90
Total Accounts Receivable
152.40
69.10
65.70
86.10
199.60
241.40
Other Current Assets
28.30
27.50
37.20
74.40
-
-
Total Current Assets
359.90
228.90
369.60
299.40
409.30
813.20
Net Property, Plant & Equipment
4.30
3.60
2.20
1.60
5.80
5
Total Investments and Advances
0.00
0.00
0.00
0.00
0.00
-
Intangible Assets
16.30
11.70
7.00
2.40
-
-
Total Assets
380.50
244.20
378.90
303.30
415.20
818.20
Accounts Payable
56.70
55.40
21.50
38.60
23.20
Other Current Liabilities
67.90
52.30
31.70
60.60
63.70
Total Current Liabilities
124.60
107.70
53.20
99.20
86.90
Total Liabilities
124.60
107.70
53.20
99.20
86.90
Common Equity (Total)
255.80
136.50
325.60
204.20
328.30
Total Shareholders' Equity
255.80
136.50
325.60
204.20
328.30
Total Equity
255.80
136.50
325.60
204.20
328.30
Liabilities & Shareholders' Equity
380.50
244.20
378.90
303.30
415.20

About Physiomics

View Profile
Address
The Magdalen Centre
Oxford Oxfordshire OX4 4GA
United Kingdom
Employees -
Website http://www.physiomics-plc.com
Updated 07/08/2019
Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. Its services include target validation, mechanism of action studies, lead selection, clinical PK or PD, EasyAP or cardiac toxicity service, virtual tumour preclinical, and virtual tumour clinical. The company was founded by David A.